These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38737696)
1. An innovative prognostic auxiliary for colon adenocarcinoma based on zinc finger protein genes. Xu F; Sun J; Gu X; Zhou Q Transl Cancer Res; 2024 Apr; 13(4):1623-1641. PubMed ID: 38737696 [TBL] [Abstract][Full Text] [Related]
2. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
3. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
4. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
5. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y Front Genet; 2022; 13():816173. PubMed ID: 35281843 [No Abstract] [Full Text] [Related]
6. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
7. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction. Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859 [TBL] [Abstract][Full Text] [Related]
8. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
9. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Huang Y; Gong P; Su L; Zhang M Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210 [TBL] [Abstract][Full Text] [Related]
11. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related]
12. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma. Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K Front Oncol; 2022; 12():904464. PubMed ID: 35912258 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis and experimental verification of the mechanism of action of T cell-mediated tumor-killing related genes in Colon adenocarcinoma. Chen J; Wang Z; Zhu Q; Ren S; Xu Y; Wang G; Zhou L Transl Oncol; 2024 May; 43():101918. PubMed ID: 38412662 [TBL] [Abstract][Full Text] [Related]
14. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy. Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y Front Genet; 2022; 13():975404. PubMed ID: 36699444 [No Abstract] [Full Text] [Related]
15. Construction and validation of a bladder cancer risk model based on autophagy-related genes. Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018 [TBL] [Abstract][Full Text] [Related]
16. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma. Liu X; Fang X; Lu L; Liu G Front Genet; 2022; 13():996625. PubMed ID: 36568396 [No Abstract] [Full Text] [Related]
18. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M; Mu J; Wang J; Zhou Q; Wang J Front Oncol; 2022; 12():961213. PubMed ID: 35965536 [TBL] [Abstract][Full Text] [Related]
19. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma. Zhang J; Liu Z; Chen W; Liu H Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]